Prestige Consumer reports FY26 adj EPS $4.38; acquires LaCorium Health for $150M

Prestige Consumer Healthcare Inc.

FY26 revenue $1,088.7M (-4.3% YoY); adjusted diluted EPS $4.38 vs $4.52 prior year.
Q4 revenue $281.6M (-5% YoY); adjusted diluted EPS $1.23 vs $1.32.
Acquiring LaCorium Health (Australian therapeutic skincare) for ~$150M cash; expected close Q2 FY27.
LaCorium TTM revenue ~$40M; expected ~$12M EBITDA with synergies.
FY27 outlook: organic revenue growth 1-3%, adj EPS $4.42-$4.51, FCF $250M+.

item 1.01 item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Prestige Consumer Healthcare Inc. reported financial results for the fiscal quarter and year ended March 31, 2026.

Period: the fiscal quarter and year ended March 31, 2026
Result: reported results

Exact text from the filing

On May 13, 2026, the Company announced financial results for the fiscal quarter and year ended March 31, 2026. A copy of the press release announcing the Company's earnings results for the fiscal quarter and year ended March 31, 2026 is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Prestige Consumer Healthcare Inc. entered into Sale and Purchase Deed with Tailor Investments Pty Limited and Standive Pty Limited valued at approximately $150 million in cash (effective 2026-05-10).

Action: entry
Agreement: asset purchase
Counterparty: Tailor Investments Pty Limited and Standive Pty Limited
Value: approximately $150 million in cash
Effective: 2026-05-10

Exact text from the filing

On May 10, 2026, PBH Australia Holding Company Pty Limited ("Purchaser"), an Australian company and a wholly owned indirect subsidiary of Prestige Consumer Healthcare Inc. (the "Company"), and Care Pharmaceuticals Pty Limited ("Care"), an Australian company and a wholly owned indirect subsidiary of the Company, entered into a definitive agreement (the "Sale and Purchase Deed") with Tailor Investments Pty Limited and Standive Pty Limited, both Australian companies (the "Sellers"), Steven David Sher, Delon Badler and Clive Howard Sher.

View on SEC.gov

Browse all earnings releases →

Prestige Consumer Healthcare Inc. filing history →

Source: SEC EDGAR

accession 0001295947-26-000013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.